- Home
- ABUS vs GSBC Comparison
ABUS vs GSBC Comparison
Compare ABUS & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- GSBC
- Stock Information
- Founded
- ABUS 2005
- GSBC 1923
- Country
- ABUS United States
- GSBC United States
- Employees
- ABUS N/A
- GSBC N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- GSBC Major Banks
- Sector
- ABUS Health Care
- GSBC Finance
- Exchange
- ABUS Nasdaq
- GSBC Nasdaq
- Market Cap
- ABUS 670.3M
- GSBC 665.7M
- IPO Year
- ABUS N/A
- GSBC N/A
- Fundamental
- Price
- ABUS $3.43
- GSBC $55.65
- Analyst Decision
- ABUS Strong Buy
- GSBC Hold
- Analyst Count
- ABUS 4
- GSBC 2
- Target Price
- ABUS $5.50
- GSBC $59.50
- AVG Volume (30 Days)
- ABUS 610.0K
- GSBC 43.7K
- Earning Date
- ABUS 07-31-2025
- GSBC 07-15-2025
- Dividend Yield
- ABUS N/A
- GSBC 2.88%
- EPS Growth
- ABUS N/A
- GSBC 10.52
- EPS
- ABUS N/A
- GSBC 5.60
- Revenue
- ABUS $6,403,000.00
- GSBC $219,572,000.00
- Revenue This Year
- ABUS $3.35
- GSBC N/A
- Revenue Next Year
- ABUS N/A
- GSBC $1.04
- P/E Ratio
- ABUS N/A
- GSBC $9.99
- Revenue Growth
- ABUS N/A
- GSBC N/A
- 52 Week Low
- ABUS $2.71
- GSBC $47.58
- 52 Week High
- ABUS $4.73
- GSBC $68.02
- Technical
- Relative Strength Index (RSI)
- ABUS 50.84
- GSBC 44.88
- Support Level
- ABUS $3.46
- GSBC $55.11
- Resistance Level
- ABUS $3.65
- GSBC $56.55
- Average True Range (ATR)
- ABUS 0.12
- GSBC 1.20
- MACD
- ABUS -0.00
- GSBC -0.16
- Stochastic Oscillator
- ABUS 35.29
- GSBC 22.31
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.